Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Promising clinical trial results reported for Medeva's Hepagene as vaccine and treatment

Oct. 23, 1997

Axcan completes phase III trial for H. pylori eradication

Oct. 22, 1997

OraVax to develop new treatments for Clostridium difficile-associated disease

Oct. 22, 1997

Diagnon receives NCI grant for H. pylori research

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Schering-Plough extends collaboration with Pharmacopeia to include hepatitis

Oct. 14, 1997

ImmuCell receives grant to develop TravelGAM

Oct. 10, 1997

CCK-A antagonists for the treatment of pancreatitis

Oct. 9, 1997

First approval for Infergen

Oct. 8, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...